CLEVELAND, Ohio – The FDA approves a drug to treat chronic yeast infections, and Brain stimulation may help smokers quit, research suggests.

Cleveland.com is rounding up some of the most notable local and national health news making headlines online. Here’s what you need to know for Tuesday, May 3.

FDA approves drug for chronic yeast infections

The Food and Drug Administration recently approved the oral drug oteseconazole (Vivjoa), making it the first approved drug for treating chronic yeast infections, Mycovia Pharmaceuticals announced.

The drug is approved only for women with recurrent vulvovaginal candidiasis (RVVC) who are infertile or postmenopausal, because the drug poses a risk to embryos and fetuses. Recurrent vulvovaginal candidiasis is defined as three or more symptomatic acute episodes of yeast infection within 12 months.

Approval was based on a trio of phase III trials – two global trials and one in the United States – including 875 patients across 11 countries.

The most frequent side effects were headache and nausea.

Brain stimulation may help smokers quit, research suggests

Some smokers who are struggling to quit might benefit from brain stimulation, a French research paper suggests.

Smokers who received noninvasive brain stimulation using low-intensity electric or magnetic impulses were twice as likely to abstain from cigarettes over three to six months as those who received placebo brain stimulation, suggests a new study review. The review combined data from seven previously published studies that included nearly 700 patients.

The journal Addiction recently published the study review.

“In the near future, noninvasive brain stimulation might be recognized as a promising new option for assisting individuals who wish to stop smoking,” lead researcher Dr. Benjamin Petit said in a news release.

Currently, smokers can try nicotine patches, counseling, hypnosis and addiction medicines to help them quit.

Living kidney donors via laparoscopic surgery have minimal risk of complications, study suggests

A new Mayo Clinic study suggests that the risk of major complications for people who donate a kidney via laparoscopic surgery is minimal. A 20-year Mayo Clinic study of more than 3,000 living kidney donors found that only 2.5% of patients in the study experienced major complications, and all recovered completely.

The study was recently published in Mayo Clinic Proceedings.

Patients who receive a kidney from a living donor generally have better outcomes, and living donor kidneys usually function longer than those from deceased donors.

The retrospective study is believed to be the largest research study to date to examine the risks associated with living kidney donation via laparoscopic surgery. The study involved 3,002 living kidney donors who underwent laparoscopic living kidney donor surgery at the Mayo Clinic transplant center from Jan. 1, 2000, this is Dec. 31, 2019. The study tracked complications that occurred up to 120 days after surgery.

Overall, 12.4% of patients had post-surgical complications, with most of them experiencing an infection or hernia related to the incision. No patients died. About 76% of those complications happened after the patient was discharged, researchers found.

Kids who see domestic violence at risk of depression as adults, study suggests

Witnessing domestic violence as a child can raise the risk of depression and other mental health problems in adulthood, a new Canadian study suggests.

More than 17,700 Canadian adults took part in a national survey on mental health. Of those respondents, 326 said they witnessed parental domestic violence more than 10 times before age 16, which was defined as chronic.

Among those who were exposed to chronic parental domestic violence as children, 22.5% had major depression at some point in their life, 15% had an anxiety disorder and nearly 27% had a substance abuse disorder, researchers said. In comparison, the rates among people with no history of violence between their parents were 9%, 7% and 19%, respectively.

On the positive side, more than three in five adults who experienced chronic violence between their parents during childhood had excellent mental health, researchers said.

The findings were published recently in the Journal of Family Violence.

By admin

Leave a Reply

Your email address will not be published.